View the Jonas Salk ethical assessment profile
This assessment does not reduce the subject to one moral ranking. Each dimension is scored separately from −100 to +100 and must be read with its evidence and uncertainty.
Scorecard status: Recalculated under multidimensional system
The assessment covers development of the first successful inactivated polio vaccine, participation in large clinical trials and creation of a collaborative nonprofit research institute.
The score evaluates documented public conduct during the stated period. It does not measure inherent human worth, does not constitute a legal verdict and remains open to correction when stronger evidence becomes available.
Salk’s scientific leadership produced an intervention of extraordinary public benefit and helped establish a durable research institution. Properly recognising collaborators still leaves a strongly positive personal record.
This assessment presents six separate ethical dimensions rather than one overall moral score. Each result must be read with its evidence, plausible range, confidence, disputes, exclusions, severe-harm findings and sources.
| Domain | Score | Intensity | Confidence |
|---|---|---|---|
| Consequences | +98.0 | 98.0 | B — high |
| Rights and duties | +88.0 | 88.0 | B — high |
| Virtue and character | +84.0 | 84.0 | B — high |
| Intentions | +94.0 | 94.0 | B — high |
| Care | +95.0 | 95.0 | B — high |
| Justice | +86.0 | 86.0 | B — high |
| Wisdom and judgment | +93.0 | 93.0 | B — high |
| Baseline ethics | +91.0 | 91.0 | B — high |
| Positive pole | Negative pole | Score | Intensity | Confidence | Reasoning |
|---|---|---|---|---|---|
| Human dignity | Dehumanisation | +91.0 | 91.0 | B — high | Calculated from 1 reviewed evidence item(s) concerning Human dignity and Dehumanisation. |
| Care | Neglect | +95.0 | 95.0 | B — high | Calculated from 1 reviewed evidence item(s) concerning Care and Neglect. |
| Benefit | Harm | +98.0 | 98.0 | B — high | Calculated from 1 reviewed evidence item(s) concerning Benefit and Harm. |
| Benevolent intention | Malicious intention | +94.0 | 94.0 | B — high | Calculated from 1 reviewed evidence item(s) concerning Benevolent intention and Malicious intention. |
| Justice | Injustice | +86.0 | 86.0 | B — high | Calculated from 1 reviewed evidence item(s) concerning Justice and Injustice. |
| Respect for rights | Violation of rights | +88.0 | 88.0 | B — high | Calculated from 1 reviewed evidence item(s) concerning Respect for rights and Violation of rights. |
| Integrity | Corruption | +84.0 | 84.0 | B — high | Calculated from 1 reviewed evidence item(s) concerning Integrity and Corruption. |
| Wisdom | Ignorance | +93.0 | 93.0 | B — high | Calculated from 1 reviewed evidence item(s) concerning Wisdom and Ignorance. |
The dominant evidence concerns a safe and effective vaccine that prevented paralysis and death on a vast scale, together with institution-building for future biomedical research.
The score is moderated by the collective nature of vaccine science, ethical questions inherent in mid-century mass trials and the risk of overstating any one scientist’s sole contribution.
SAL-C1
The successful inactivated polio vaccine became a central tool in controlling a feared and disabling disease.
SAL-R1
The vaccine expanded practical protection against a disease that imposed severe burdens without meaningful individual control.
SAL-V1
He pursued rigorous testing and public-health application while working within a large collaborative scientific effort.
SAL-I1
His central scientific and institutional aims were prevention of human suffering and advancement of knowledge.
SAL-CA1
The work moved beyond discovery to a vaccine capable of protecting large populations of children.
SAL-J1
Mass vaccination made protection available beyond those able to purchase individual treatment after illness.
SAL-W1
He combined laboratory research, staged testing and large trials to address a major public-health threat.
SAL-B1
The vaccine protected children from preventable disability and expanded their opportunity to live without fear of polio.
Vaccine development depended on earlier virology, laboratory teams, funders, trial organisers and participants. Attribution is therefore limited to Salk’s documented scientific and institutional leadership.
Popular quotations and patent claims not necessary to establish the ethical value of the work were excluded.
No corrections have been recorded.